Opendata, web and dolomites

MArylAND SIGNED

At the host-bacteria interface: Modulation of the intestinal microbiota and its metabolic activity by Card9 signalling in health and Inflammatory Bowel Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MArylAND project word cloud

Explore the words cloud of the MArylAND project. It provides you a very rough idea of what is the project "MArylAND" about.

altered    tryptophan    lives    predisposition    treatments    strategies    mice    seem    deciphering    integrative    disease    receptor    pathologies    nutrition    scientific    ligands    host    innovative    expand    sokol    network    collaborative    hydrocarbon    techniques    showed    fungi    patients    receptors    microorganisms    environmental    microbial    decipher    mechanisms    recruitment    exhibit    therapeutic    inflammatory    gnotobiotic    card9    fragile    domain    types    cutting    purpose    bacteria    impaired    genotype    interface    microbiota    immunosuppressive    susceptibility    influences    lox    cell    metabolic    strengthen    alteration    plan    advantage    skills    conceptual    metabolise    always    animals    intestine    aryl    metabolomics    balance    genetic    caspase    acquire    protein    individuals    activating    bowel    incidence    ibd    preventive    community    humans    genes    biology    transcriptomics    colleagues    metabolites    cre    ahr    gut    ecosystem    mirrors    modulation    me    colitis    health    codes    edge    crosstalk    environment    combination    human   

Project "MArylAND" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT 

Organization address
address: Rue De L'Universite 147
city: PARIS CEDEX 07
postcode: 75338
website: www.inra.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 185˙076 €
 EC max contribution 185˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-11-01   to  2020-02-20

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT FR (PARIS CEDEX 07) coordinator 185˙076.00

Map

 Project objective

The microbial community in the human intestine is crucial to the health and nutrition of the host. Loss of the fragile balance within this complex ecosystem is involved in numerous pathologies, including inflammatory bowel disease (IBD). The incidence of IBD is increasing and affects individuals in challenging years of their lives, with immunosuppressive treatments that are not always effective. IBD results from a combination of genetic predisposition, alteration of the gut microbiota, and environmental influences. Thus, deciphering the host-bacteria crosstalk will improve our understanding of IBD and enable new preventive and therapeutic strategies. Caspase recruitment domain 9 (Card9), one of the IBD susceptibility genes, codes for a protein involved in the response to fungi and bacteria. Sokol and colleagues showed that Card9-/- mice have an increased susceptibility to colitis, due to an altered gut microbiota that is not able to metabolise tryptophan into aryl hydrocarbon receptor (AhR) ligands. In humans, comparable mechanisms seem to be involved, as microbiota of IBD patients exhibit impaired production of AhR ligands, which mirrors the Card9-/- genotype. We aim to decipher the mechanisms involved in the modulation of the microbiota and its metabolic activity by Card9. For this purpose, we will take advantage of a strong collaborative environment and cutting-edge techniques, including gnotobiotic animals, cre-lox technology, transcriptomics, metabolomics and systems biology. Specifically, we plan to identify (i) new pathways and cell types involved in the modulation of the microbiota and its metabolic activity, and (ii) microorganisms and metabolites activating AhR receptors in the gut. This highly innovative and integrative project will allow me to expand my conceptual and technical knowledge of the gut-microbiota interface, acquire new key skills and strengthen my scientific network.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARYLAND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARYLAND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

BirthControlEnvirons (2019)

Contraception meets the environment: everyday contraceptive practices, politics, and futures in a toxic age

Read More  

MIGPSC (2018)

Shaping the European Migration Policy: the role of the security industry

Read More  

PI3K MODULATORS (2019)

Identification and characterisation of new class of PI3K modulators in oncology

Read More